CV Sciences (CVSI) Assets Average (2011 - 2026)
CV Sciences (CVSI) reported Assets Average of $6.8 million for Q1 2026, down 12.77% on a YoY basis from $7.8 million in Q1 2025, and down 1.96% sequentially from $7.0 million in Q4 2025.
CV Sciences (CVSI) Assets Average (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Assets Average data on file, last reported at $6.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 12.77% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (down 12.77% YoY), and the FY2025 full-year result was $7.4 million, down 13.07% from the prior year.
- Assets Average retreated to $6.8 million in Q1 2026, from $7.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $18.2 million in Q1 2022 to a low of $4.1 million in Q4 2024.
- A 5-year average of $10.0 million and a median of $8.8 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slumped 56.12% in 2024 and soared 68.81% in 2025, its largest moves.
- Tracing CVSI's Assets Average over 5 years: stood at $14.0 million in 2022, then slumped by 32.5% to $9.4 million in 2023, then tumbled by 56.12% to $4.1 million in 2024, then soared by 68.81% to $7.0 million in 2025, then dropped by 1.96% to $6.8 million in 2026.
- Business Quant data shows CVSI's Assets Average at $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 6.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 8.68 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Dec 31, 2023 | 9.42 Mn |
| Sep 30, 2023 | 9.76 Mn |
| Jun 30, 2023 | 10.67 Mn |
| Mar 31, 2023 | 12.10 Mn |
| Dec 31, 2022 | 13.96 Mn |
| Sep 30, 2022 | 15.47 Mn |
| Jun 30, 2022 | 17.01 Mn |
| Mar 31, 2022 | 18.17 Mn |
| Dec 31, 2021 | 20.84 Mn |
| Sep 30, 2021 | 25.71 Mn |
| Jun 30, 2021 | 29.24 Mn |